Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Retromer complex protein levels are reduced in Down syndrome brain tissue, correlating with Alzheimer's disease neuropathology.
• The impact of in vivo retromer system targeting on cognitive and synaptic function in Down syndrome is not well understood.

Purpose of the Study:

• To investigate the effects of pharmacological retromer stabilization on cognitive and synaptic functions in a mouse model of Down syndrome.

Main Methods:

• Ts65dn mice received TPT-172 (a pharmacological chaperone) or vehicle from 4 to 9 months of age.
• Cognitive function was assessed, and hippocampal slices were used to record field potentials after TPT-172 incubation to evaluate synaptic plasticity.

Main Results:

• TPT-172 treatment enhanced cognitive performance in Ts65dn mice.
• Incubation of hippocampal slices with TPT-172 improved synaptic function.

Conclusions:

• Pharmacological retromer stabilization enhances synaptic plasticity and memory in a mouse model of Down syndrome.
• These findings support the potential of retromer stabilization as a therapeutic strategy for Down syndrome.